Blue Bay Ventures

Blue Bay Ventures is a venture capital firm established in 2021 and based in the Cayman Islands. The firm focuses on investing in early-stage companies, primarily within the technology and blockchain sectors. By concentrating on these innovative areas, Blue Bay Ventures aims to support and foster the growth of emerging businesses that are shaping the future of technology.

Nico Pantelis

Partner

12 past transactions

Particula

Seed Round in 2025
Particula is a leading provider of analytics and quality assessment for digital assets, reducing due diligence times and mitigating operational risks for financial leaders. The platform offers advanced risk ratings and comprehensive analyses across technical, economic, environmental, and compliance dimensions. This ensures that investors gain instant security, enhanced market access, and clearer insights. With aggregated on- and off-chain data from diverse sources, Particula transforms investment strategies and streamlines operations.

Brickken

Seed Round in 2025
Brickken offers a comprehensive Digital Asset Suite that enables businesses to create, trade, and manage tokenized financial instruments using blockchain technology. The company provides a no-code solution that simplifies the tokenization process, allowing organizations of any size to enter the blockchain economy without the need for intermediaries. By facilitating the creation, issuance, and management of digital assets in a single platform, Brickken enhances accessibility for investors and promotes a frictionless experience. This approach positions Brickken as a significant player in the emerging Web3 landscape, where it aims to empower companies and investors alike to navigate the tokenization of various assets efficiently.

AccuPulse

Venture Round in 2024
AccuPulse is developing novel pulsed electric field ablation (PFA) generator and catheters.

Guiling Medical

Series A in 2024
Guiling Medical is a medical device company that provides reliable, advanced medical device products for complex wounds and refractory infections

Finoa

Venture Round in 2024
Finoa GmbH, founded in 2018 and based in Potsdam, Germany, provides regulated custody and asset-servicing solutions for digital assets. The company operates a digital asset platform that allows institutional investors and corporations to securely store and manage cryptographic tokens. Finoa's services include custody and staking, designed to accommodate users of varying familiarity with cryptocurrencies. The platform features advanced security measures such as multi-signature processing, biometric fingerprint access, and cryptographically secured private keys. As a qualified custodian supervised by the German Federal Financial Supervisory Authority, Finoa serves a diverse clientele, including venture capital firms, large corporations, and financial institutions, ensuring the safe and intuitive management of digital assets. The company is co-founded by Christopher May and Henrik Gebbing and is supported by several prominent financial investors.

Rouling Technology

Seed Round in 2023
Rouling Technology focuses on the research of non-invasive brain-computer interface technology.

WillVision

Seed Round in 2023
Wellsees is an ophthalmology big data medical technology enterprise. They offer research in ophthalmology and optometry as well as industrial technology research, development, and production, enterprise management, and quality management systems, and characteristics of high-tech medical technology.

Pedo-care

Seed Round in 2023
Pedo-care focuses on R&D, design, manufacturing, and sales of children's medical appliances. Pedo-care's main product is the children's nebulizer, is specifically designed and created for children.

Kactus Biosystems

Series B in 2022
Kactus Biosystems is a biotechnology company that designs and manufactures high-quality and bioactive recombinant proteins. The company is committed to improving cutting-edge therapeutic technologies such as cell therapies, gene editing, immunotechnology, and vaccines. They test the configurations of your protein/enzyme in various expression systems after creating 3D models of it to optimize protein folding, maximize bioactivity, and improve stability. Their focus is on customization and tailored solutions, so your potential for innovation is limitless.

Zhihui Medical

Seed Round in 2022
Zhihui Medical is a technology company that is engaged in the transformation of local original scientific research. They provide diagnosis, treatment, and care for tumor diseases. They are an innovative technology company with integrated medical services. The innovation is suitable for early screening, early diagnosis, medication guidance, and prognosis monitoring of tumor diseases.

Security Token Group

Series A in 2022
Security Token Group is a company focused on providing information and resources related to security token offerings (STOs) for the investor community. It offers a platform that facilitates cryptocurrency investments by creating tokenized investment products that are entirely built and managed using blockchain technology. The platform aims to develop refined trading markets that are simple, transparent, and valuable for users, enabling secure participation in security token trading. Originally known as Security Token Partners, the company rebranded to its current name in 2018, reflecting its commitment to advancing the security token market.

DigiShares

Seed Round in 2022
DigiShares provides white-label solutions for security token issuance, corporate management, and trading. The company supports process related to investor registration and verification and token purchase, and for the longer-term management of a group of tokenized investors, the platform will maintain the share cap table, facilitate communication with investors, facilitate votes, facilitate shareholder meetings, etc. As a special feature, it also offers an internal OTC exchange where existing and new investors can trade their shares within a single project.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.